Overview

Academic scientists often find it challenging to negotiate consulting agreements with biotechnology or pharmaceutical companies. The legal language can be confusing, anxieties can occur on both sides, specifics concerning stock shares and options can be obscure, and there are pitfalls aplenty, yet raising objections or making counterproposals may feel awkward and potentially risky. This book is an essential guide for academic scientists and physicians considering consulting work in biomedicine. The authors, a seasoned attorney and a Nobel Prize-winning scientist, have extensive experience in reviewing and negotiating consulting agreements. In an accessible style, they guide scientists through key contractual issues, including intellectual property management, confidentiality, fees, indemnity, and stock options and classes, as well as the laws such agreements must satisfy. As the science of biomedicine continues to skyrocket, biomedical consulting has become an attractive option for a wider range of career stages. This is the most authoritative and practically useful handbook available to any scientist considering this important step in career advancement.

Full Product Details

9781621821076

Table of Contents

Reviews

Consulting agreements between academic scientists and corporations not only protect discoveries and intellectual property, but also deal with risks related to securities laws, such as insider trading. Giving advice requires an in depth understanding of these issues and the different cultures of academicians versus corporate lawyers. Edward Klees and Robert Horvitz have applied the same degree of rigor that characterizes the best academic research to understanding the principles and subtleties of these agreements. They provide a clear description of critical issues that are understood by surprisingly few, e.g., liquidation preferences and participation rights of preferred stock. This section alone makes Connecting with Companies worthwhile reading for any academic scientist with an interest in the corporate world. - Ansbert K. Gadicke, Managing Director, MPM Capital This is the book I wish had been available when I started my first company. I learned an enormous amount from it. - Roger Tsien, University of California at San Diego, Nobel Laureate in Chemistry, 2008 I loved this book and all potential consultants in the biomedical field will find it enlightening. I highly recommend it. - Katherine Ku, Director of the Office of Technology Licensing, Stanford University In this valuable guide, the authors provide a crisp introduction to key issues in academic-industry interactions, making it a must-read for any academic contemplating entry into a consulting agreement. - Marc Tessier-Lavigne, President, The Rockefeller University The book is exceptionally to the point--and useful. I've recommended it to our senior staff for themselves and for the faculty they deal with. - Lita Nelsen, Director, Technology Licensing Office, Massachusetts Institute of Technology Consulting agreements between academic scientists and corporations not only protect discoveries and intellectual property, but also deal with risks related to securities laws, such as insider trading. Giving advice requires an in depth understanding of these issues and the different cultures of academicians versus corporate lawyers. Edward Klees and Robert Horvitz have applied the same degree of rigor that characterizes the best academic research to understanding the principles and subtleties of these agreements. They provide a clear description of critical issues that are understood by surprisingly few, e.g., liquidation preferences and participation rights of preferred stock. This section alone makes Connecting with Companies worthwhile reading for any academic scientist with an interest in the corporate world. - Ansbert K. Gadicke, Managing Director, MPM Capital This is the book I wish had been available when I started my first company. I learned an enormous amount from it. - Roger Tsien, University of California at San Diego, Nobel Laureate in Chemistry, 2008 I loved this book and all potential consultants in the biomedical field will find it enlightening. I highly recommend it. - Katherine Ku, Director of the Office of Technology Licensing, Stanford University In this valuable guide, the authors provide a crisp introduction to key issues in academic-industry interactions, making it a must-read for any academic contemplating entry into a consulting agreement. - Marc Tessier-Lavigne, President, The Rockefeller University The book is exceptionally to the point--and useful. I've recommended it to our senior staff for themselves and for the faculty they deal with. - Lita Nelsen, Director, Technology Licensing Office, Massachusetts Institute of Technology This is the book I wish had been available when I started my first company. I learned an enormous amount from it. - Roger Tsien, University of California at San Diego, Nobel Laureate in Chemistry, 2008 I loved this book and all potential consultants in the biomedical field will find it enlightening. I highly recommend it. - Katherine Ku, Director of the Office of Technology Licensing, Stanford University Consulting agreements between academic scientists and corporations protect discoveries and intellectual property and address legal aspects of their commercial development. In this book, the authors apply academic rigor to the principles and subtleties of these agreements, making it worthwhile reading for any academic scientist with an interest in the corporate world. - Ansbert K. Gadicke, Managing Director, MPM Capital In this valuable guide, the authors provide a crisp introduction to key issues in academic-industry interactions, making it a must-read for any academic contemplating entry into a consulting agreement. - Marc Tessier-Lavigne, President, The Rockefeller University The book is exceptionally to the point--and useful. I've recommended it to our senior staff for themselves and for the faculty they deal with. - Lita Nelsen, Director, Technology Licensing Office, Massachusetts Institute of Technology

Consulting agreements between academic scientists and corporations not only protect discoveries and intellectual property, but also deal with risks related to securities laws, such as insider trading. Giving advice requires an in depth understanding of these issues and the different cultures of academicians versus corporate lawyers. Edward Klees and Robert Horvitz have applied the same degree of rigor that characterizes the best academic research to understanding the principles and subtleties of these agreements. They provide a clear description of critical issues that are understood by surprisingly few, e.g., liquidation preferences and participation rights of preferred stock. This section alone makes Connecting with Companies worthwhile reading for any academic scientist with an interest in the corporate world. - Ansbert K. Gadicke, Managing Director, MPM Capital This is the book I wish had been available when I started my first company. I learned an enormous amount from it. - Roger Tsien, University of California at San Diego, Nobel Laureate in Chemistry, 2008 I loved this book and all potential consultants in the biomedical field will find it enlightening. I highly recommend it. - Katherine Ku, Director of the Office of Technology Licensing, Stanford University In this valuable guide, the authors provide a crisp introduction to key issues in academic-industry interactions, making it a must-read for any academic contemplating entry into a consulting agreement. - Marc Tessier-Lavigne, President, The Rockefeller University The book is exceptionally to the point--and useful. I've recommended it to our senior staff for themselves and for the faculty they deal with. - Lita Nelsen, Director, Technology Licensing Office, Massachusetts Institute of Technology Consulting agreements between academic scientists and corporations not only protect discoveries and intellectual property, but also deal with risks related to securities laws, such as insider trading. Giving advice requires an in depth understanding of these issues and the different cultures of academicians versus corporate lawyers. Edward Klees and Robert Horvitz have applied the same degree of rigor that characterizes the best academic research to understanding the principles and subtleties of these agreements. They provide a clear description of critical issues that are understood by surprisingly few, e.g., liquidation preferences and participation rights of preferred stock. This section alone makes Connecting with Companies worthwhile reading for any academic scientist with an interest in the corporate world. - Ansbert K. Gadicke, Managing Director, MPM Capital This is the book I wish had been available when I started my first company. I learned an enormous amount from it. - Roger Tsien, University of California at San Diego, Nobel Laureate in Chemistry, 2008 I loved this book and all potential consultants in the biomedical field will find it enlightening. I highly recommend it. - Katherine Ku, Director of the Office of Technology Licensing, Stanford University In this valuable guide, the authors provide a crisp introduction to key issues in academic-industry interactions, making it a must-read for any academic contemplating entry into a consulting agreement. - Marc Tessier-Lavigne, President, The Rockefeller University The book is exceptionally to the point--and useful. I've recommended it to our senior staff for themselves and for the faculty they deal with. - Lita Nelsen, Director, Technology Licensing Office, Massachusetts Institute of Technology This is the book I wish had been available when I started my first company. I learned an enormous amount from it. - Roger Tsien, University of California at San Diego, Nobel Laureate in Chemistry, 2008 I loved this book and all potential consultants in the biomedical field will find it enlightening. I highly recommend it. - Katherine Ku, Director of the Office of Technology Licensing, Stanford University Consulting agreements between academic scientists and corporations protect discoveries and intellectual property and address legal aspects of their commercial development. In this book, the authors apply academic rigor to the principles and subtleties of these agreements, making it worthwhile reading for any academic scientist with an interest in the corporate world. - Ansbert K. Gadicke, Managing Director, MPM Capital In this valuable guide, the authors provide a crisp introduction to key issues in academic-industry interactions, making it a must-read for any academic contemplating entry into a consulting agreement. - Marc Tessier-Lavigne, President, The Rockefeller University The book is exceptionally to the point--and useful. I've recommended it to our senior staff for themselves and for the faculty they deal with. - Lita Nelsen, Director, Technology Licensing Office, Massachusetts Institute of Technology

Author Information

Edward Klees is General Counsel at the University of Virginia Investment Management Company, where he works on private equity and hedge fund investment and legal issues relating to general investment management. He is an Adjunct Professor at the University of Virginia School of Law and Vice Chair of the American Bar Association's (ABA) Institutional Investor Committee. Klees frequently speaks on institutional investment issues at the ABA and other legal and investment conferences. Formerly, he was Associate General Counsel at the Howard Hughes Medical Institute. He has extensive background in the review and negotiation of biomedical consulting contracts. H. Robert Horvitz is currently at the Massachusetts Institute of Technology, where he is Professor of Biology and a member of the McGovern Institute for Brain Research and Koch Institute for Integrative Cancer Research. He is also an Investigator at the Howard Hughes Medical Institute. He currently serves as the Chair of the Board of Trustees for Society for Science & the Public and is a member of the Board of Trustees at Massachusetts General Hospital. Horvitz shared the 2002 Nobel Prize in Physiology or Medicine with Sydney Brenner and John Sulston. In 2009, he was named a Foreign Member of the Royal Society.

Tab Content 6

Customer Reviews

Recent Reviews

Countries Available